---
title: "InsulinRatio: Diabetes Dose - Reviews, Revenue and Downloads in United States | Apple App Store"
description: "InsulinRatio is an INFORMATIONAL helper for the I:C dose plus optional BG correction. Always defer to your endocrinologist and your pump or pen. Save your I:C, target BG, and correction factor in sett"
---

# InsulinRatio: Diabetes Dose — United States
> Carb Bolus Calculator Helper

![InsulinRatio App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/eb/1c/5f/eb1c5fa4-9129-d819-1d5d-62a71ca37a91/AppIcon-0-0-1x_U007epad-0-1-85-220.png/434x0w.png)

**Developer:** [26 Branding Agency](https://apptail.io/developer/26-branding-agency-Ewqfb)
**Category:** Health Fitness
**Rating:** N/A (0 ratings)
**Price:** $2.99
**Bundle ID:** com.x26branding.insulinratio
**Store:** Apple App Store
**Country:** United States
**Version:** 1.0.2 (released 2026-06-29)
**Original Release:** 2026-06-02
**Languages:** English

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/us/app/app/id6772955535)
**AppTail Page:** [https://apptail.io/app/insulinratio-diabetes-dose-ixLA/united-states](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/united-states)

## InsulinRatio Description
InsulinRatio is an INFORMATIONAL helper for the I:C dose plus optional BG correction. Always defer to your endocrinologist and your pump or pen. Save your I:C, target BG, and correction factor in settings; carbs + current BG come from each meal.

Medical disclaimer: InsulinRatio is an informational calculator only. It is not medical advice and not a medical device. Always seek the advice of your doctor or diabetes care team before using this app and before making any insulin, dose, or treatment decision. Do not change your insulin based on this app. Incorrect insulin dosing can cause serious harm.

## InsulinRatio Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/28/6c/e1/286ce1c7-fcbf-3008-e09d-89aab0c480d9/1-hero-en.png/1290x2796.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/26/66/b1/2666b162-04e0-18fc-058a-68fd419d56bc/2-biweekly-en.png/1290x2796.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/ed/e9/5c/ede95cce-5a5b-9f8e-65c4-bf18d132e2f1/3-about-en.png/1290x2796.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/fe/ab/c0/feabc040-db63-cb87-fff7-ff130c1ba05e/4-history-en.png/1290x2796.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/e9/65/8a/e9658a64-fb8e-a083-8398-b61047b69935/5-monthly-en.png/1290x2796.png)







## InsulinRatio Available In
- [Azerbaijan](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/azerbaijan)
- [Bulgaria](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/bulgaria)
- [Czechia](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/czechia)
- [India](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/india)
- [Kazakhstan](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/kazakhstan)
- [Philippines](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/philippines)
- [Pakistan](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/pakistan)
- [United States](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/united-states)
- [Uzbekistan](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/uzbekistan)
- [Vietnam](https://apptail.io/app/insulinratio-diabetes-dose-ixLA/vietnam)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*
